Selected research
Industry Research
Scopolamine Transdermal Patch Industry Research Report 2026
Market perspective
The global Scopolamine Transdermal Patch market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Scopolamine Transdermal Patch is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Scopolamine Transdermal Patch is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Scopolamine Transdermal Patch is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Scopolamine Transdermal Patch include Novartis, Mylan, GSK, BengbuBBCATushan Pharmaceutical Co, Perrigo and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Scopolamine Transdermal Patch market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Scopolamine Transdermal Patch Market by Company
Novartis
Mylan
GSK
BengbuBBCATushan Pharmaceutical Co
Perrigo
Baxter
Scopolamine Transdermal Patch Segment by Type
1mg
1.5mg
Scopolamine Transdermal Patch Segment by Application
Nausea/Vomiting
Parkinsonian Tremor
Motion Sickness
Others
Scopolamine Transdermal Patch Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Scopolamine Transdermal Patch market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Scopolamine Transdermal Patch and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Scopolamine Transdermal Patch.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Scopolamine Transdermal Patch manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Scopolamine Transdermal Patch by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Scopolamine Transdermal Patch in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1mg
- 1.5mg
Applications
- Nausea/Vomiting
- Parkinsonian Tremor
- Motion Sickness
- Others
Companies covered
- Novartis
- Mylan
- GSK
- BengbuBBCATushan Pharmaceutical Co
- Perrigo
- Baxter
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Scopolamine Transdermal Patch Market Size (2021-2032)
- 2.2.2 Global Scopolamine Transdermal Patch Sales (2021-2032)
- 2.2.3 Global Scopolamine Transdermal Patch Market Average Price (2021-2032)
- 2.3 Scopolamine Transdermal Patch by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1mg
- 2.3.3 1.5mg
- 2.4 Scopolamine Transdermal Patch by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Nausea/Vomiting
- 2.4.3 Parkinsonian Tremor
- 2.4.4 Motion Sickness
- 2.4.5 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Scopolamine Transdermal Patch Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Scopolamine Transdermal Patch Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Scopolamine Transdermal Patch Revenue of Manufacturers (2021-2026)
- 3.4 Global Scopolamine Transdermal Patch Average Price by Manufacturers (2021-2026)
- 3.5 Global Scopolamine Transdermal Patch Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Scopolamine Transdermal Patch, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Scopolamine Transdermal Patch, Product Type & Application
- 3.8 Global Manufacturers of Scopolamine Transdermal Patch, Established Date
- 3.9 Global Scopolamine Transdermal Patch Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Novartis
- 4.1.1 Novartis Company Information
- 4.1.2 Novartis Business Overview
- 4.1.3 Novartis Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Novartis Scopolamine Transdermal Patch Product Portfolio
- 4.1.5 Novartis Recent Developments
- 4.2 Mylan
- 4.2.1 Mylan Company Information
- 4.2.2 Mylan Business Overview
- 4.2.3 Mylan Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Mylan Scopolamine Transdermal Patch Product Portfolio
- 4.2.5 Mylan Recent Developments
- 4.3 GSK
- 4.3.1 GSK Company Information
- 4.3.2 GSK Business Overview
- 4.3.3 GSK Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 GSK Scopolamine Transdermal Patch Product Portfolio
- 4.3.5 GSK Recent Developments
- 4.4 BengbuBBCATushan Pharmaceutical Co
- 4.4.1 BengbuBBCATushan Pharmaceutical Co Company Information
- 4.4.2 BengbuBBCATushan Pharmaceutical Co Business Overview
- 4.4.3 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 BengbuBBCATushan Pharmaceutical Co Scopolamine Transdermal Patch Product Portfolio
- 4.4.5 BengbuBBCATushan Pharmaceutical Co Recent Developments
- 4.5 Perrigo
- 4.5.1 Perrigo Company Information
- 4.5.2 Perrigo Business Overview
- 4.5.3 Perrigo Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Perrigo Scopolamine Transdermal Patch Product Portfolio
- 4.5.5 Perrigo Recent Developments
- 4.6 Baxter
- 4.6.1 Baxter Company Information
- 4.6.2 Baxter Business Overview
- 4.6.3 Baxter Scopolamine Transdermal Patch Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Baxter Scopolamine Transdermal Patch Product Portfolio
- 4.6.5 Baxter Recent Developments
5 Global Scopolamine Transdermal Patch Market Scenario by Region
- 5.1 Global Scopolamine Transdermal Patch Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Scopolamine Transdermal Patch Sales by Region: 2021-2032
- 5.2.1 Global Scopolamine Transdermal Patch Sales by Region: 2021-2026
- 5.2.2 Global Scopolamine Transdermal Patch Sales by Region: 2027-2032
- 5.3 Global Scopolamine Transdermal Patch Revenue by Region: 2021-2032
- 5.3.1 Global Scopolamine Transdermal Patch Revenue by Region: 2021-2026
- 5.3.2 Global Scopolamine Transdermal Patch Revenue by Region: 2027-2032
- 5.4 North America Scopolamine Transdermal Patch Market Facts & Figures by Country
- 5.4.1 North America Scopolamine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Scopolamine Transdermal Patch Sales by Country (2021-2032)
- 5.4.3 North America Scopolamine Transdermal Patch Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.5 Europe Scopolamine Transdermal Patch Market Facts & Figures by Country
- 5.5.1 Europe Scopolamine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Scopolamine Transdermal Patch Sales by Country (2021-2032)
- 5.5.3 Europe Scopolamine Transdermal Patch Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Netherlands
- 5.6 Asia Pacific Scopolamine Transdermal Patch Market Facts & Figures by Country
- 5.6.1 Asia Pacific Scopolamine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Scopolamine Transdermal Patch Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Scopolamine Transdermal Patch Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 China Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Scopolamine Transdermal Patch Market Facts & Figures by Country
- 5.7.1 South America Scopolamine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Scopolamine Transdermal Patch Sales by Country (2021-2032)
- 5.7.3 South America Scopolamine Transdermal Patch Revenue by Country (2021-2032)
- 5.7.4 Mexico
- 5.7.5 Brazil
- 5.7.6 Argentina
- 5.8 Middle East and Africa Scopolamine Transdermal Patch Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Scopolamine Transdermal Patch Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Scopolamine Transdermal Patch Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Scopolamine Transdermal Patch Revenue by Country (2021-2032)
- 5.8.4 Turkey
- 5.8.5 Saudi Arabia
- 5.8.6 UAE
6 Segment by Type
- 6.1 Global Scopolamine Transdermal Patch Sales by Type (2021-2032)
- 6.1.1 Global Scopolamine Transdermal Patch Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Scopolamine Transdermal Patch Sales Market Share by Type (2021-2032)
- 6.2 Global Scopolamine Transdermal Patch Revenue by Type (2021-2032)
- 6.2.1 Global Scopolamine Transdermal Patch Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Scopolamine Transdermal Patch Revenue Market Share by Type (2021-2032)
- 6.3 Global Scopolamine Transdermal Patch Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Scopolamine Transdermal Patch Sales by Application (2021-2032)
- 7.1.1 Global Scopolamine Transdermal Patch Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Scopolamine Transdermal Patch Sales Market Share by Application (2021-2032)
- 7.2 Global Scopolamine Transdermal Patch Revenue by Application (2021-2032)
- 7.2.1 Global Scopolamine Transdermal Patch Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Scopolamine Transdermal Patch Revenue Market Share by Application (2021-2032)
- 7.3 Global Scopolamine Transdermal Patch Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Scopolamine Transdermal Patch Value Chain Analysis
- 8.1.1 Scopolamine Transdermal Patch Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Scopolamine Transdermal Patch Production Mode & Process
- 8.2 Scopolamine Transdermal Patch Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Scopolamine Transdermal Patch Distributors
- 8.2.3 Scopolamine Transdermal Patch Customers
9 Global Scopolamine Transdermal Patch Analyzing Market Dynamics
- 9.1 Scopolamine Transdermal Patch Industry Trends
- 9.2 Scopolamine Transdermal Patch Industry Drivers
- 9.3 Scopolamine Transdermal Patch Industry Opportunities and Challenges
- 9.4 Scopolamine Transdermal Patch Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst